Generation Bio Co. financial data

Symbol
GBIO on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 628% % -11.72%
Debt-to-equity 178% % 59%
Return On Equity -94.82% % 9.6%
Return On Assets -34.14% % 31%
Operating Margin -457.06% % 46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,737,899 shares -89.91%
Common Stock, Shares, Outstanding 6,735,676 shares -89.91%
Entity Public Float $155,200,000 USD -48.16%
Common Stock, Value, Issued $1,000 USD -85.71%
Weighted Average Number of Shares Outstanding, Basic 6,735,454 shares 0.92%
Weighted Average Number of Shares Outstanding, Diluted 6,735,454 shares 0.92%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $15,270,000 USD -17.82%
Research and Development Expense $67,980,000 USD -7.8%
General and Administrative Expense $37,320,000 USD -12.19%
Operating Income (Loss) $-69,793,000 USD 56%
Nonoperating Income (Expense) $10,722,000 USD -10.28%
Net Income (Loss) Attributable to Parent $-62,627,000 USD 57%
Earnings Per Share, Basic 0 USD/shares 64%
Earnings Per Share, Diluted 0 USD/shares 64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $21,940,000 USD 1.3%
Marketable Securities, Current $67,682,000 USD -58.51%
Accounts Receivable, after Allowance for Credit Loss, Current $391,000 USD -82.32%
Other Assets, Current $160,000 USD -44.83%
Assets, Current $93,462,000 USD -51.13%
Property, Plant and Equipment, Net $8,853,000 USD -44.7%
Operating Lease, Right-of-Use Asset $17,429,000 USD -17.86%
Other Assets, Noncurrent $0 USD -100%
Assets $121,896,000 USD -51%
Accounts Payable, Current $2,064,000 USD 24%
Employee-related Liabilities, Current $10,335,000 USD 129%
Liabilities, Current $21,040,000 USD -30.25%
Operating Lease, Liability, Noncurrent $19,744,000 USD -76.21%
Other Liabilities, Noncurrent $0 USD
Liabilities $71,336,000 USD -50.58%
Accumulated Other Comprehensive Income (Loss), Net of Tax $8,000 USD -97.49%
Retained Earnings (Accumulated Deficit) $-744,290,000 USD -9.19%
Stockholders' Equity Attributable to Parent $50,560,000 USD -51.59%
Liabilities and Equity $121,896,000 USD -51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-28,360,000 USD 11%
Net Cash Provided by (Used in) Financing Activities $-125,000 USD -100.35%
Net Cash Provided by (Used in) Investing Activities $2,957,000 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 6,735,676 shares -89.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24,092,000 USD 1.2%
Deferred Tax Assets, Valuation Allowance $214,316,000 USD 22%
Operating Lease, Liability $62,000,000 USD
Payments to Acquire Property, Plant, and Equipment $246,000 USD -87.17%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-62,938,000 USD 57%
Property, Plant and Equipment, Gross $38,204,000 USD -16.02%
Operating Lease, Liability, Current $6,352,000 USD -41.17%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $105,051,000 USD 8.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Operating Lease, Payments $1,900,000 USD -38.71%
Additional Paid in Capital $794,841,000 USD 1.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $4,855,000 USD -5.64%
Deferred Tax Assets, Net of Valuation Allowance $222,032,000 USD 12%
Share-based Payment Arrangement, Expense $8,841,000 USD -49.47%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%